TG Therapeutics is working to develop a subcutaneous, or under-the-skin, version of Briumvi (ublituximab-xiiy), its approved therapy for relapsing forms of multiple sclerosis (MS). The company ...
How much do you know about multiple sclerosis (MS)? Test your understanding with this quick quiz and see how well you grasp the basics of MS, including its types, causes, symptoms, and testing.